NEUROCRINE BIOSCIENCES INC (NBIX) › RevenueNEUROCRINE BIOSCIENCES INC (NBIX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $15.00M2017: $161.63M2018: $451.20M2019: $788.10M2020: $1.05B2021: $1.13B2022: $1.49B2023: $1.89B2024: $2.36B2025: $2.86B$2.86B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$2.86B+21.4%2024$2.36B+24.8%2023$1.89B+26.8%2022$1.49B+31.3%2021$1.13B+8.4%2020$1.05B+32.7%2019$788.10M+74.7%2018$451.20M+179.2%2017$161.63M+977.5%2016$15.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share